Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 12, 2016 7:49 AM ET

Healthcare Equipment and Supplies

Company Overview of Celleration, Inc.

Company Overview

Celleration, Inc., a medical device company, develops and commercializes therapeutic ultrasound healing technologies in the United States. It offers MIST Therapy, a painless, noncontact, and low frequency ultrasound delivered through a saline mist to the wound bed. The company serves patients, medical professionals, and payers. Celleration, Inc. was formerly known as Advanced Medical Applications, Inc. The company was founded in 1999 and is based in Eden Prairie, Minnesota. As of May 29, 2015, Celleration, Inc. operates as a subsidiary of Alliqua BioMedical, Inc.

6321 Bury Drive

Suite 15

Eden Prairie, MN 55346

United States

Founded in 1999





Key Executives for Celleration, Inc.

Chief Executive Officer, President and Director
Age: 58
Vice President of Medical Affairs
Vice President of Research & Development
Area Director of Sales - Western US
Area Director of Sales - Eastern US
Compensation as of Fiscal Year 2015.

Celleration, Inc. Key Developments

Alliqua, Inc., Celleration Inc. - M&A Call

To discuss the acquisition of Celleration, Inc.

Celleration, Inc. Announces Statistically Significant Better Healing with MIST® Therapy in the IN-BALANCE VLU Randomized Control Trial

Celleration Inc. announced the publication of results from the IN-BALANCE VLU prospective, randomized controlled trial in the January edition of Ostomy & Wound Management. IN-BALANCE was conducted in 22 US outpatient healthcare facilities comparing the percent wound area reduction after 4 weeks of treatment with guideline-driven standard care (SC) plus MIST Ultrasound Healing Therapy (MIST + SC) to SC alone in nonresponding lower extremity venous leg ulcers (VLU). Of the 112 eligible participants, 81 were identified as non-responding during the two week run-in period and were randomized. The average wound size reduction at 4 weeks was 61.6% in the MIST+SC compared to 45% in the SC alone group (P = 0.02). The statistical significance was unchanged when adjusting for wound size and age. In addition, MIST Therapy showed a statistically significant reduction in pain (P = 0.01) during the same period.

Celleration Inc. Announces FDA Clearance for Next Generation UltraMIST System

Celleration Inc. announced that they received FDA clearance for their next generation UltraMIST(TM) System. The UltraMIST System is Celleration's latest addition to its line of MIST(R) Therapy products. MIST Therapy is low-frequency ultrasound delivered through a saline mist to accelerate wound healing. Unlike conventional wound treatments that are limited to treating the surface, MIST Therapy delivers ultrasound energy into and below the wound bed to stimulate cells and shorten the healing process.

Similar Private Companies By Industry

Company Name Region
KyoMedix Inc. United States
Axiom Technology Partners, LLC United States
Acme-Monaco Corporation United States
Erie Medical United States
Interwest Medical Equipment Distributors, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Celleration, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at